SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis
4 references·0 citing·18 second hopsampled
Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis (2018)Cost Effectiveness of Hepatocellular Carc…Cost‐effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C (2004)Cost‐effectiveness of screeni…Screening for Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis: A Cost-Utility Analysis (2003)Screening for Hepatocellular …Health-State Utilities and Quality of Life in Hepatitis C Patients (2003)Health-State Utilities and Qu…Assessment of Utilities and Health-Related Quality of Life in Patients With Chronic Liver Disease (2001)Assessment of Utilities and H…Cost-Effectiveness in Health and Medicine (1996)Modeling Valuations for EuroQol Health States (1997)SF-36 Health Survey Update (2000)Systematic Review: Health-State Utilities in Liver Disease: A Systematic Review (2008)The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons (2008)Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms (2020)The Markov Process in Medical Prognosis (1983)Methods for the economic evaluation of health care programmes (1987)Markov Models in Medical Decision Making (1993)Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis (2008)The burden of illness associated with hepatocellular carcinoma in the United States (2008)SF-36 physical and mental health summary scales : a user's manual (1994)Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes (1995)Assessment of Quality-of-Life Outcomes (1996)First- and Second-Line Bevacizumab in Addition to Chemotherapy for Metastatic Colorectal Cancer: A United States–Based Cost-Effectiveness Analysis (2015)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis (1999)Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United States (2017)
this work references cited by second hop· second hop is a sample of the most-cited connections

References

  • 2003Health-State Utilities and Quality of Life in Hepatitis C Patients277 cited
  • 2003Screening for Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis: A Cost-Utility Analysis252 cited
  • 2001Assessment of Utilities and Health-Related Quality of Life in Patients With Chronic Liver Disease178 cited
  • 2004Cost‐effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C168 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work